Similar articles for PMID: 18841054

Year	Number of Results
2002	1
2003	3
2004	1
2005	10
2006	5
2007	9
2008	5
2009	2
2010	9
2011	7
2012	5
2013	9
2014	8
2015	10
2016	7
2017	10
2018	3
2019	1
2020	1
2021	3
2022	4
2023	3
2024	0

1

Demethylating agents in myeloid malignancies.

Garcia-Manero G. Garcia-Manero G. Curr Opin Oncol. 2008 Nov;20(6):705-10. doi: 10.1097/CCO.0b013e328313699c. Curr Opin Oncol. 2008. PMID: 18841054 Free PMC article. Review.

2

Results of phase 2 randomized study of low-dose decitabine with or without valproic acid in patients with myelodysplastic syndrome and acute myelogenous leukemia.

Issa JP, Garcia-Manero G, Huang X, Cortes J, Ravandi F, Jabbour E, Borthakur G, Brandt M, Pierce S, Kantarjian HM. Issa JP, et al. Cancer. 2015 Feb 15;121(4):556-61. doi: 10.1002/cncr.29085. Epub 2014 Oct 21. Cancer. 2015. PMID: 25336333 Free PMC article. Clinical Trial.

3

The role of decitabine in the treatment of myelodysplastic syndromes.

Atallah E, Kantarjian H, Garcia-Manero G. Atallah E, et al. Expert Opin Pharmacother. 2007 Jan;8(1):65-73. doi: 10.1517/14656566.8.1.65. Expert Opin Pharmacother. 2007. PMID: 17163808 Review.

4

Decitabine in the treatment of myelodysplastic syndromes.

Santos FP, Kantarjian H, Garcia-Manero G, Issa JP, Ravandi F. Santos FP, et al. Expert Rev Anticancer Ther. 2010 Jan;10(1):9-22. doi: 10.1586/era.09.164. Expert Rev Anticancer Ther. 2010. PMID: 20014881 Review.

5

Current status of epigenetic treatment in myelodysplastic syndromes.

Kuendgen A, Lübbert M. Kuendgen A, et al. Ann Hematol. 2008 Aug;87(8):601-11. doi: 10.1007/s00277-008-0477-9. Epub 2008 Apr 5. Ann Hematol. 2008. PMID: 18392623 Review.

6

Review: recent clinical trials in epigenetic therapy.

Oki Y, Issa JP. Oki Y, et al. Rev Recent Clin Trials. 2006 May;1(2):169-82. doi: 10.2174/157488706776876490. Rev Recent Clin Trials. 2006. PMID: 18473969 Review.

7

Targeting epigenetic pathways in acute myeloid leukemia and myelodysplastic syndrome: a systematic review of hypomethylating agents trials.

Yun S, Vincelette ND, Abraham I, Robertson KD, Fernandez-Zapico ME, Patnaik MM. Yun S, et al. Clin Epigenetics. 2016 Jun 14;8:68. doi: 10.1186/s13148-016-0233-2. eCollection 2016. Clin Epigenetics. 2016. PMID: 27307795 Free PMC article. Review.

8

Clinical development of decitabine as a prototype for an epigenetic drug program.

Rosenfeld CS. Rosenfeld CS. Semin Oncol. 2005 Oct;32(5):465-72. doi: 10.1053/j.seminoncol.2005.07.002. Semin Oncol. 2005. PMID: 16210087 Review.

9

Clinical experience with decitabine in North American patients with myelodysplastic syndrome.

Yee KW, Jabbour E, Kantarjian HM, Giles FJ. Yee KW, et al. Ann Hematol. 2005 Dec;84 Suppl 1:18-24. doi: 10.1007/s00277-005-0019-7. Ann Hematol. 2005. PMID: 16273408

10

Digging deep into "dirty" drugs - modulation of the methylation machinery.

Pleyer L, Greil R. Pleyer L, et al. Drug Metab Rev. 2015 May;47(2):252-79. doi: 10.3109/03602532.2014.995379. Epub 2015 Jan 8. Drug Metab Rev. 2015. PMID: 25566693 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year